JBIO: Aerovate Therapeutics, Inc. Company Short-Term Debt
The market capitalization of Aerovate Therapeutics Inc (JBIO) plummeted following failed tests of its primary drug, forcing management to urgently restructure its governance. Geopolitical tensions and sanctions are further hindering international research into immune agents. This chart of the market value of a specific short-term debt, which currently stands at 0.00, reflects the position of the developer of medical drugs and human health enhancement products.
Metric breakdowns and analytics for Aerovate Therapeutics, Inc. (JBIO)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Aerovate Therapeutics Inc|JBIO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Aerovate|JBIO - Company Total Debt|Debt to Book Capitalization Ratio Aerovate Therapeutics|JBIO - Company Long-Term Liabilities|Company Current Liabilities Aerovate Therapeutics Inc|Quick Liquidity aerovatetx.com
- net income and valuation multiples indicators:
Initial company analysis:JBIO - aerovatetx.com
The operational activities of Aerovate Therapeutics Inc (JBIO) are reflected in the dynamics of liabilities through short-term debt statistics. This indicator captures daily market equilibrium points, shaping the business's current liquidity profile. Comparing this metric with industry averages allows for an assessment of the efficiency of borrowed capital management. For a developer of orphan drugs, moderate leverage is essential to fund costly research and protect patents. An optimal balance of loans prevents growth stagnation and confirms high asset quality.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|ZBIO - Company Short-Term Debts|IMNM: Company Short-Term Debts|Short-Term Debt gossamerbio.com (GOSS)|Company Short-Term Debt KalVista Pharmaceuticals, Inc.|SEPN: Company Short-Term Loans and Borrowings|Company Short-Term Debt Pieris Pharmaceuticals Inc (PVLA)|SVRA - Short-Term Debt|Rigel Pharmaceuticals - Company Current Liabilities|anaptysbio.com - Company Short-Term Debt|Astria Therapeutics, Inc. - Company Short-Term Debts|ENGN - Company Short-Term Debts|RAPT (RAPT Therapeutics) - Company Current Liabilities|ACRS: Amount of Current Liabilities|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|Short-Term Debt tizianalifesciences.com TLSA|Company Current Liabilities CABA (Cabaletta Bio)|VTYX (Ventyx Biosciences Inc.) - Company Short-Term Loans and Borrowings|Theratechnologies Inc - Company Current Liabilities|Amount of Current Liabilities AVTX (Avalo Therapeutics Inc)|Eledon Pharmaceuticals - Company Short-Term Debts|Company Short-Term Loans and Borrowings AGEN (agenusbio.com)|CLYM: Company Short-Term Debts|Short-Term Debt zurabio.com (ZURA)|Company Short-Term Debt aTyr|ADAG: Company Short-Term Loans and Borrowings|Company Short-Term Debts IMA|Company Short-Term Debts shattucklabs.com (STTK)|Company Short-Term Debt Equillium EQ|CNTB (Connect Biopharma Holdings) - Current Liabilities|Immunic Inc - Company Short-Term Debts|Short-Term Debt Atara Biotherapeutics|IFRX (inflarx.de) - Company Current Liabilities|x4pharma.com (XFOR) - Company Short-Term Debts|Company Current Liabilities ACET|CELU (Celularity Corp) - Amount of Current Liabilities|Company Short-Term Debts INMB|Short-Term Debt Volume Barinthus Biotherapeutics Corp|Company Short-Term Debts KZR (Kezar Life Sciences)|SABS - Company Current Liabilities|AKTX - Company Short-Term Debt|Short-Term Debt Volume Enlivex Therapeutics ENLV|QTTB (q32bio.com) - Company Current Liabilities|GeoVax Corp - Company Short-Term Loans and Borrowings|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|ibioinc.com (IBIO) - Short-Term Debt Volume|Company Short-Term Debt Carisma Therapeutics (CARM)|XTL Biopharmaceuticals Ltd - Company Short-Term Indebtedness|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|HCWB - Company Current Liabilities|APVO - Company Short-Term Debt|aimimmuno.com - Amount of Current Liabilities|ADTX: Company Short-Term Debts|GRI (GRI Bio Inc) - Company Short-Term Debt|XRTX (XORTX) - Company Short-Term Debts|Vyome Therapeutics (HIND) - Short-Term Debt Volume|Company Short-Term Debt Revelation Biosciences (REVB)|INDP - Short-Term Debt|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|CALI (CalciMedica Inc) - Current Liabilities|Affimed Therapeutics - Company Short-Term Debts|Company Short-Term Loans and Borrowings ALLK (Allakos Inc.)|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Short-Term Debt iTeos Therapeutics, Inc.|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Company Current Liabilities Third Harmonic Bio Inc THRD